Literature DB >> 8957040

L-arginine metabolism in immune-mediated glomerulonephritis in the rat.

M Ketteler1, N Ikegaya, D K Brees, W A Border, N A Noble.   

Abstract

Low-protein diets slow the progression of some renal diseases. We recently found that dietary restriction of L-arginine markedly ameliorates disease in antithymocyte serum-induced glomerulonephritis in the rat, suggesting that L-arginine may play a key role in the beneficial effects of low-protein diets. L-arginine is metabolized by nitric oxide synthases to nitric oxide and L-citrulline or by arginase to urea and L-ornithine. L-ornithine is a precursor for polyamines, which are required for cell proliferation and for proline, an essential component of collagen. In a time course of disease, we found that inducible nitric oxide synthase gene expression and nitric oxide production were increased very early. Arginase activity was significantly increased until 5 days of disease. Ornithine decarboxylase, the rate-limiting step for polyamine synthesis, was increased at 3 days coincident with the onset of cell proliferation. Gene expression of ornithine aminotransferase, a proline synthetic enzyme, was increased from day 1, paralleling increased collagen synthesis. Thus, the three pathways of L-arginine metabolism are upregulated in a manner consistent with their possible roles in the cell lysis, cell proliferation, and collagen deposition, which characterize this model of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957040     DOI: 10.1016/s0272-6386(96)90388-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

Review 1.  [Nitric oxide, L-arginine and the kidney. Experimental studies of new therapy approaches].

Authors:  M Ketteler; F Abou-Rebyeh; A Frey; A Gawlik; H Peters; R Westenfeld; A Distler
Journal:  Med Klin (Munich)       Date:  1998-01-15

2.  Arginase acts as an alternative pathway of L-arginine metabolism in experimental colon anastomosis.

Authors:  M B Witte; N Vogt; C Stuelten; T Gotoh; M Mori; H D Becker
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

3.  Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation.

Authors:  Xuejuan Li; Fangrui Ding; Suxia Wang; Baihong Li; Jie Ding
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.